Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2002-05-24
2010-02-23
Rawlings, Stephen L (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000, C530S388100, C530S391300
Reexamination Certificate
active
07666997
ABSTRACT:
Antibodies that will specifically bind to NBS-1 are described. It is also shown that NBS-1 will interact with p53 responsive elements in a p53 promoter. Thus, NBS-1 can be used in subjects having a p53-dependent tumor to inhibit growth of that tumor.
REFERENCES:
patent: 4478744 (1984-10-01), Mezei et al.
patent: 5001225 (1991-03-01), Taylor
patent: 5468468 (1995-11-01), LaRochelle et al.
patent: 2004/0253232 (2004-12-01), Jakobovits et al.
patent: 2005/0202016 (2005-09-01), Caput et al.
patent: WO 97/28186 (1997-08-01), None
Roitt et al (Immunology, 1993, Mosby, St. Louis, p. 6.4-6.5).
Herbert et al (The Dictionary of Immunology, Academic Press, 3rd Edition, London, 1985, pp. 58-59.
Vojtesek et al (Br. J. Cancer, 1993, 67:1254-8.
Roitt et al, 1998, Immunology, 4th ed, Mosby, London, (p. 7.7-7.8).
Holmes (Exp. Opin.Invest. Drugs, 2001, 10(3):511-519).
Herbert et al. (The Dictionary of Immunology, Academic Press, 4th edition, 1995, p. 58).
Greenspan et al. (Nature Biotechnology 7:936-937 (1999)).
See http://www.answers.com/topic/antigenic-determinant-1, Antigenic Determinant.
Cruse et al (Illustrated Dictionary of Immunology, CRC Press, New York, p. 241, 1995).
Stratagene Catalog 1988, p. 39.
Genbank A35658.
Genbank I40377.
Genbank T13230.
Geysen et al (1984, PNAS, 81:3998).
Agarwal et al (1996, J. Immunol., 157:2779-2787).
Stites and Terr Eds, Basic and Clinical Immunology, Seventh Edition,, 1991, Appleton and Lange, East Norwalk, Connecticut.
Xu et al (Onc., 27:3501-3507, 2008).
Greenspan et al. (Nature Biotechnology. 1999; 7: 936-937).
Daniel et al (Virology, 202:540-549, 1994).
Immunology for Life Scientists (Ed. Eales, p. 14, 2003).
Bost et al. (Immunol. Invest. 1998; 17:577-586).
Weiss et al (PNAS, 88:5484-5488, 1991).
Ben-Yehoyoda et al (JBC, 273(36):34475-34482, 2003).
M. Kaghad et al., “Cell”, 90(4):808-819 (1997).
S. Dickman, “Science”, 277(5332):1605-1606 (1997).
C. Jost et al., “Nature”, 389(6647):191-194 (1997).
B. Clurman et al., “Nature”, 389(6647):122-123 (1997).
M. Oren, “Cell”, 90(5):829-832 (1997).
Levine, et al., “Nature”, 351:453-456 (1991).
Hollstein et al., “Science”, 253:49-53 (1991).
Haffer et al., “Curr Opin. Genet. Dev.”, 5:84-90 (1995).
Kern et al., “Science”, 256:827-830 (1992).
Versteeg et al., “Eur. J. Cancer”, 31A:538-541 (1995).
Bowie et al., “Science”, 247:1306-1310 (1990).
Burgess et al., “J. Cell. Bio.”, 111:2129-2138 (1990).
Lazar et al., “Molecular and Cellular Biology”, 8:1247-1252 (1988).
Herbert, “The Dictionary of Immunology, Academic Press, Loneon”, p. 58 (1996).
Shuster et al., “Cell Motility Cytoskeleton”, 35:175-187 (1996).
Webster's II New Riverside Dictionary, The Riverside Publishing Co., Boston, p. 1262 (1988).
Kaghad et al., (Y11416), Genbank Sequence Database (Acession E308621), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Md) (1998).
Yang et al., (AFO75436), Genbank Sequence Database (Acession G3695094), National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD) (1998).
Osada et al., (AB16073), Genbank Sequence Database (Acession D1033557), National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD) (1988).
Vojtesek et al., (Oncogene, 10:389-393) (1995).
Queen et al., (PNAS, 86:10029-10033) (1989).
Jost Christine
Kaelin William
Dana-Farber Cancer Institute Inc.
Duffy Brad
Fish & Richardson P.C.
Rawlings Stephen L
LandOfFree
Methods of treatment using NBS-1, antibodies and proteins... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment using NBS-1, antibodies and proteins..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment using NBS-1, antibodies and proteins... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4187483